About Dian Diagnostics Group Company

The company takes third-party diagnostic services as its core business and strives to provide integrated solutions for medical diagnosis. The company was founded in 1996 and went public in July 2011. With the mission of “let Chinese people share health on an equal footing”, the company actively lays out the industrial ecological chain, covering fields such as medical diagnostic services, diagnostic technology research and development, diagnostic product production and marketing, CRO, forensic testing, health management, and cold chain logistics. The company's main business involves medical diagnostic services, diagnostic technology research and development, production and sales of diagnostic products, CRO, forensic testing, health management, etc. The company has its own three product lines: molecular diagnosis, pathological diagnosis, and mass spectrometry diagnosis. Corporate honors: The company won “2018 China Service Outsourcing Pharmaceutical and Health Industry Star”, “2018 China's Top 100 Service Outsourcing Growth Enterprise”, Zhejiang Provincial People's Government Quality Award “Nomination Award”, “Zhejiang Top 30 Listed Companies Internal Control Award”, “Top 100 Listed Companies”, Chairman Chen Haibin of the company won “Outstanding Hangzhou Businessman”, Zhejiang Provincial People's Government Quality Award, and a national specialized and innovative “Little Giant” enterprise, and won many awards such as “2023 Outstanding Intelligent Manufacturing Model Award”, “Hangzhou Patent Demonstration Enterprise” and “Zhejiang Enterprise Research Institute”.